Axcelis Technologies Inc (ACLS) — chart, structure and Closelook read

Pick a ticker to load its detail page.

Signals for this name

Every Closelook reading that exists for ACLS, from the same nightly bakes the boards use. Research diary readings, not advice.

Vacuum, gas-delivery, and ultra-high-purity fluids. The fab plumbing without which the headline tools are paperweights.

Compared against ACLS on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

About Axcelis Technologies Inc

Axcelis Technologies Inc (ACLS) trades on US exchanges, classified under Technology. It is a constituent of Rubin Build-Out 100, sitting in Layer 6 of the build-out stack.

The Closelook company score reads 44/100 composite (momentum 39, quality 38, valuation 38) across 7 modules — the full three-layer breakdown, chart structure and analog history load live above.

closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-09-15

Quick answers

What is Axcelis Technologies Inc (ACLS)?

Axcelis Technologies Inc trades as ACLS on the US exchange (US) and is classified under Technology in the Closelook research universe, as of the registry build of 2026-09-15.

Is ACLS in a Closelook index?

Yes — Axcelis Technologies Inc is a constituent of Rubin Build-Out 100, as of 2026-09-15.

What is Axcelis Technologies Inc's Closelook composite score?

44 out of 100, with momentum 39, quality 38 and valuation 38 sub-scores, as of 2026-09-15. Scores are Closelook's own research readings, not ratings or investment advice.

What does this page show?

A live price chart with SMA overlays and drawing tools for ACLS, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe